Comparison of Budesonide Turbuhaler with Budesonide Aqua in the Treatment of Seasonal Allergic Rhinitis

William H Yang; Jerry Dolovich; Michel A Drouin; Paul Keith; Jennifer Haddon; Barbara Jennings; the Rhinocort Study Group

doi:10.1155/1998/639710

Canadian Respiratory Journal (Jan 1998)

Comparison of Budesonide Turbuhaler with Budesonide Aqua in the Treatment of Seasonal Allergic Rhinitis

William H Yang,
Jerry Dolovich,
Michel A Drouin,
Paul Keith,
Jennifer Haddon,
Barbara Jennings,
the Rhinocort Study Group

Affiliations

William H Yang: Section of Allergy and Clinical Immunology, Department of Medicine, University of Ottawa, Ottawa, Canada
Jerry Dolovich: Division of Clinical Immunology and Allergy, McMaster University, Hamilton, Canada
Michel A Drouin: Section of Allergy and Clinical Immunology, Department of Medicine, University of Ottawa, Ottawa, Canada
Paul Keith: Division of Clinical Immunology and Allergy, McMaster University, Hamilton, Canada
Jennifer Haddon: Astra Pharma Inc, Mississauga, Ontario, Canada
Barbara Jennings: Astra Pharma Inc, Mississauga, Ontario, Canada
the Rhinocort Study Group

DOI: https://doi.org/10.1155/1998/639710
Journal volume & issue: Vol. 5, no. 6
pp. 455 – 460

Abstract

Read online

OBJECTIVE: To compare the effect of budesonide Turbuhaler 400 µg/day with budesonide aqua 256 µg/day in the treatment of seasonal allergic rhinitis (SAR). Secondarily to ascertain patients' preferences for the two nasal devices and to assess quality of life.

Published in Canadian Respiratory Journal

ISSN: 1198-2241 (Print); 1916-7245 (Online)
Publisher: Wiley
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the respiratory system
Website: https://onlinelibrary.wiley.com/journal/7503

About the journal